Outpatient clinic visits with a nephrologist associated with lower risk of mortality in patients with acute kidney injury

Outpatient clinic visits with a nephrologist and attention to kidney complications and cardiovascular disease were associated with 29% lower risk of mortality compared to standard of care in patients with AKI during recent hospitalization.

Survivors of acute kidney injury (AKI) are a high-risk population, but many gaps exist in follow-up care. At a tertiary-care hospital, patients seen by the nephrology inpatient service with moderate to severe AKI are referred at discharge to an AKI follow-up clinic where they receive a standardized assessment that emphasizes management of cardiovascular risk and kidney complications. Researchers compared outcomes among patients who attended the AKI follow-up clinic to similar patients who received standard care.

While attendance at the AKI follow-up clinic was not associated with less dialysis or kidney disease, it was associated with lower mortality and more prescriptions for some cardioprotective medications. These findings, recently published in the American Journal of Kidney Diseases (AJKD), illustrate potential benefits of an AKI follow-up clinic, requiring confirmation in randomized trials.

Source:
Journal reference:

Silver, S.A., et al. (2022) Association of an Acute Kidney Injury Follow-up Clinic With Patient Outcomes and Care Processes: A Cohort Study. American Journal of Kidney Diseases. doi.org/10.1053/j.ajkd.2022.10.011.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Multiomic signatures identified for rapid detection and treatment of high-risk T-ALL